Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-23 Martin Samuel Bates SVP and CFO Option exercise +3,750 $2.78 $10K 33,878
2021-12-23 Martin Samuel Bates SVP and CFO Sale −9,500 $42.00 $399K 24,378
2021-12-23 Martin Samuel Bates SVP and CFO Option exercise · Incentive Stock Option (Right to Buy) −3,250 9,530
2021-12-23 Martin Samuel Bates SVP and CFO Option exercise · Incentive Stock Option (Right to Buy) −3,750 24,421
2021-12-08 Cavanaugh Sarah SVP of Corp Affairs & Admin. Option exercise +1,857 $9.02 $17K 2,265
2021-12-08 Cavanaugh Sarah SVP of Corp Affairs & Admin. Option exercise +5,466 $10.38 $57K 7,731
2021-12-08 Cavanaugh Sarah SVP of Corp Affairs & Admin. Sale −7,323 $40.00 $293K 408
2021-12-08 Cavanaugh Sarah SVP of Corp Affairs & Admin. Option exercise · Incentive Stock Option (Right to Buy) −1,857 11,458
2021-12-08 Cavanaugh Sarah SVP of Corp Affairs & Admin. Option exercise · Incentive Stock Option (Right to Buy) −5,466 78,534
2021-12-08 Crowley Elizabeth Sr. VP &CPDO Option exercise +4,000 $9.02 $36K 8,726
2021-12-08 Crowley Elizabeth Sr. VP &CPDO Sale −4,000 $40.00 $160K 4,726
2021-12-08 Crowley Elizabeth Sr. VP &CPDO Option exercise · Incentive Stock Option (Right to Buy) −4,000 16,000
2021-12-08 Heath-Chiozzi Margo SVP of Regulatory Affairs Option exercise +600 $2.78 $2K 11,847
2021-12-08 Heath-Chiozzi Margo SVP of Regulatory Affairs Sale −600 $40.00 $24K 11,247
2021-12-08 Heath-Chiozzi Margo SVP of Regulatory Affairs Option exercise · Incentive Stock Option (Right to Buy) −600 41,800
2021-11-15 Martin Samuel Bates SVP and CFO Option exercise +3,250 $9.02 $29K 32,628
2021-11-15 Martin Samuel Bates SVP and CFO Option exercise +3,750 $2.78 $10K 36,378
2021-11-15 Martin Samuel Bates SVP and CFO Sale −7,452 $43.92 $327K 28,926
2021-11-15 Martin Samuel Bates SVP and CFO Sale −2,048 $42.27 $87K 26,878
2021-11-15 Martin Samuel Bates SVP and CFO Option exercise · Incentive Stock Option (Right to Buy) −3,250 12,780

Page 11 of 17 · 325 trades